313 related articles for article (PubMed ID: 17169776)
1. Cancer vaccines: toward the next revolution in cancer therapy.
Emens LA
Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
[No Abstract] [Full Text] [Related]
2. Targeting cancer therapy.
Begent RH
Br J Cancer; 1999 Jul; 80 Suppl 1():104-9. PubMed ID: 10466768
[No Abstract] [Full Text] [Related]
3. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
Sznol M
Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
[No Abstract] [Full Text] [Related]
4. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
5. The capacity of the immune system to control cancer.
HÃ¥kansson L
Eur J Cancer; 2009 Aug; 45(12):2068-70. PubMed ID: 19608409
[No Abstract] [Full Text] [Related]
6. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
7. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
Croix BS
Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
[No Abstract] [Full Text] [Related]
8. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
Fournier P; Schirrmacher V
Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
[TBL] [Abstract][Full Text] [Related]
9. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
Van den Eynde B
Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
[TBL] [Abstract][Full Text] [Related]
10. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
Oka Y; Tsuboi A; Sugiyama H
Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
[No Abstract] [Full Text] [Related]
11. Cancer vaccines: pessimism in check.
Timmerman JM; Levy R
Nat Med; 2004 Dec; 10(12):1279; author reply 1279-80. PubMed ID: 15682512
[No Abstract] [Full Text] [Related]
12. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
Spisek R
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
[No Abstract] [Full Text] [Related]
13. Improving the efficacy of cancer immunotherapy.
Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; HÃ¥kansson L
Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
[TBL] [Abstract][Full Text] [Related]
14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
15. Cancer vaccines: pessimism in check.
Mocellin S; Mandruzzato S; Bronte V; Marincola FM
Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
[No Abstract] [Full Text] [Related]
16. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
17. Technical challenges facing therapeutic cancer vaccines.
Ward S; Copier J; Dalgleish A
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
[TBL] [Abstract][Full Text] [Related]
18. Challenges for cancer vaccine development.
Tabi Z; Man S
Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
[TBL] [Abstract][Full Text] [Related]
19. [BCG-CWS as a cancer vaccine].
Hayashi A
Nihon Rinsho; 2002 May; 60 Suppl 5():614-20. PubMed ID: 12101748
[No Abstract] [Full Text] [Related]
20. A bright future for cancer vaccines. Success in early trials suggests vaccines are the next step in cancer treatment.
Duke Med Health News; 2008 Oct; 14(10):4-5. PubMed ID: 18927992
[No Abstract] [Full Text] [Related]
[Next] [New Search]